SN
Swapan Nath
About Swapan Nath
Data last updated:
Swapan Nath is a Director at Lupikem Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Lupikem Pharmaceuticals Private Limited reported revenue of ₹3.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Nov 2023 | 2023 | ₹3.3 Lakh (FY 2025) | Active |
Board colleagues of Swapan Nath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arjun Nath | 10384989 | Lupikem Pharmaceuticals Private Limited | Director |
| Joyshree Deb Nath | 10384988 | Lupikem Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swapan Nath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swapan Nath
Swapan Nath currently holds 1 directorship: Lupikem Pharmaceuticals Private Limited (Director, since 07 Nov 2023, revenue ₹3.3 Lakh (FY 2025)).
Swapan Nath was first appointed on 07 Nov 2023 as Director at Lupikem Pharmaceuticals Private Limited.
The current boards of Swapan Nath's companies include Arjun Nath (Lupikem Pharmaceuticals Private Limited), Joyshree Deb Nath (Lupikem Pharmaceuticals Private Limited).